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Abstract
Objective—to assess how informed patients are about breast reconstruction, and how involved 
they are in decision making.
Summary Background Data—Breast reconstruction is an important treatment option for 
patients undergoing mastectomy. Wide variations in who gets reconstruction, however, have led to 
concerns about decision making.
Methods—We conducted a prospective cross-sectional study of patients planning mastectomy at 
a single site, over 20 months. Before surgery, patients completed a survey with validated scales to 
assess knowledge about breast reconstruction and involvement in decision making. Factors 
associated with knowledge were examined in a multivariable linear regression model.
Corresponding author and reprint requests: Clara Nan-hi Lee, MD, MPP, UNC Plastic Surgery CB 7195, Chapel Hill, NC 27599-7195, 
Phone: 919-966-4446; Fax: 919-966-3814; cnlee@med.unc.edu. 
HHS Public Access
Author manuscript
Ann Surg. Author manuscript; available in PMC 2017 March 02.
Published in final edited form as:
Ann Surg. 2016 December ; 264(6): 1103–1109. doi:10.1097/SLA.0000000000001561.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results—145 patients enrolled (77% enrollment rate), and 126 remained eligible. The overall 
knowledge score was 58.5% (out of 100%). Knowledge about risk of complications was especially 
low at 14.3%. Knowledge did not differ by treatment (reconstruction or not). On multivariable 
analysis, non-white race was independently associated with lower knowledge. Most patients 
(92.1%) reported some discussion with a provider about reconstruction, and most (90.4%) 
reported being asked their preference. More patients reported discussing the advantages of 
reconstruction (57.9%) than the disadvantages (27.8%).
Conclusions—Women undergoing mastectomy in this sample were highly involved in decision 
making but had major deficits in knowledge about the procedure. Knowledge about the risk of 
complications was particularly low. Providers appeared to have discussed the advantages of 
reconstruction more than its disadvantages.
INTRODUCTION
Breast reconstruction is an important treatment option for women undergoing mastectomy. 
Most women who have a mastectomy are candidates for breast reconstruction, and insurance 
coverage of the procedure is mandated by federal and state laws. Most women who have a 
mastectomy, however, do not undergo reconstruction,1–3 and rates of reconstruction vary 
substantially by race/ethnicity, age, income, and geographic location.1, 3–7 The rate of 
reconstruction in white women is about 40%, whereas in African American women, it is 
about 34%, and in low-acculturated Latina women, about 14%.7
Variations in rates of breast reconstruction have led to concerns about the quality of decision 
making for the procedure. One concern is that many patients may not be receiving enough 
information to guide their decisions. In retrospective studies, approximately 20% of women 
who had mastectomy reported no discussion about breast reconstruction with their 
provider.1, 6, 8 Minority women are less likely to report a discussion about breast 
reconstruction,1, 4, 6 and they have lower knowledge about reconstruction.8 Concern also 
exists because many women are unsatisfied with their choice to receive or not receive 
reconstruction. As many as 47% of women undergoing reconstruction have reported regret 
over the decision.9 In addition, satisfaction with decisions about reconstruction is lower 
among minority women.7
Currently, it is difficult to determine whether these concerns about decision making quality 
are justified. Prior studies of breast reconstruction decisions have primarily been 
retrospective, measuring knowledge and involvement in decision making months or even 
years after treatment.1, 6, 7 Thus, how informed patients are about reconstruction at the time 
of decision making remains unclear. To better understand how patients make this decision, 
we conducted a prospective study assessing how informed patients are about breast 
reconstruction, and how involved they are in the decision making process, prior to 
mastectomy. We were specifically interested in knowledge about the advantages and 
disadvantages of reconstruction and its alternatives.
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METHODS
Study design
We conducted a prospective cohort study of patients planning to have mastectomy at a single 
site, over a 20-month period. Here we report on results from the baseline assessment. The 
site of the study was the Breast Clinic of the North Carolina Cancer Hospital, which is part 
of a National Cancer Institute-designated Comprehensive Cancer and treats approximately 
500 Stage 0-III breast patients annually. The study was approved by the University of North 
Carolina Chapel Hill Institutional Review Board and registered with clinicaltrials.gov.
Study population
Adult women (21 years or older) planning to have mastectomy were enrolled prior to 
surgery from June 2012 to February 2014. Women undergoing mastectomy for treatment of 
early stage (I-III) invasive ductal or lobular breast cancer, treatment of ductal carcinoma in 
situ (DCIS), or prophylaxis (eg, patients with BRCA mutation) were included. We excluded 
patients with stage IV disease and other histologic types (eg, sarcoma, desmoid, or 
metaplastic tumors), since their clinical courses and prognoses differ substantially from that 
of Stages 0-III lobular or ductal carcinoma. We also excluded patients with a psychiatric 
illness who could not make their own decisions. We excluded patients who could not read or 
speak English because we did not have survey measures in other languages or resources for 
interpretation.
Clinical flow
At the study site, patients with incident breast cancer or DCIS are discussed at the 
multidisciplinary conference in the morning and then seen by a surgical oncologist in 
multidisciplinary breast clinic the same day or in the surgeon’s individual clinic on another 
day. Patients who are considering post-mastectomy reconstruction see a plastic surgeon, 
usually within about 1 week.
Enrollment
The research assistant initially identified eligible patients by screening clinic schedules. She 
then confirmed eligibility at the multidisciplinary breast conference or through discussion 
with the surgical oncologist. Most eligible patients were approached in clinic, immediately 
after the surgical oncology visit, although some patients were approached by mail. 
Permission to approach the patient was confirmed with the surgical oncologist. For patients 
who were undecided about surgery (mastectomy versus partial mastectomy) at the end of the 
surgical oncology visit, the research assistant tracked them until a surgery decision was 
made, and then approached those having mastectomy about enrollment. We attempted to 
approach every eligible patient during the study period.
After patients provided informed consent, they were given a paper questionnaire, to be 
completed in clinic or at home prior to surgery. Among patients who saw a plastic surgeon 
after the surgical oncology visit, some completed the survey before the plastic surgery visit, 
and some completed it after that visit. Patients noted the date of survey completion, and we 
recorded dates of clinic visits. Patients who did not return the survey by 2 weeks after 
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enrollment were reminded with a phone call. Those who did not return the survey by 4 
weeks, and who had not yet had surgery, were mailed a reminder packet with the survey. 
Patients who completed the survey after surgery were considered ineligible and removed 
from the study. Participants were mailed a $50 gift card.
Measures
The survey contained questions about demographics, knowledge about breast reconstruction, 
and involvement in decision making. It also included questions about preferences related to 
breast reconstruction, quality of life, and emotional well-being, about which we are not 
reporting here. Demographic, medical, and treatment data were abstracted from the medical 
record.
Demographics—These questions asked about education, marital status, race, ethnicity, 
employment status, and income.
Decision Quality Instrument—The Breast Reconstruction Decision Quality 
Instrument© (DQI) was used to measure knowledge about reconstruction and involvement 
in decision making. The DQI was designed to evaluate condition-specific (rather than 
generic) knowledge, so it asks questions about specific aspects of the breast reconstruction 
process and its outcomes. Each of these aspects had been deemed by breast cancer survivors 
and providers a “key fact” about reconstruction, in the instrument development process.10 
Further details of the DQI development and validation process have been described 
before.10–12 The DQI covers three broad domains.
1. Knowledge about specifics of breast reconstruction: Nine multiple-choice items 
on the evidence about satisfaction with and without reconstruction, recovery 
time, number of surgeries, types of reconstruction, complication risk, radiation 
effects, breast cancer surveillance after reconstruction, and risk of recurrence 
after reconstruction.
2. Involvement in decision making. Four multiple choice items on whether or not 
the provider discussed the option of reconstruction, how much the advantages of 
reconstruction were discussed, how much the disadvantages of reconstruction 
were discussed, and whether or not the provider ask the patient her treatment 
preference. Additional items asked whether or not the provider discussed use of a 
prosthesis as an option, how much the provider addressed the patients’ concerns 
about how she would look after mastectomy, and how much the patient felt 
involved in decision making.
3. Goals and concerns. Seven items assess goals and concerns related to 
reconstruction. These items will be reported separately, along with other data on 
preferences.
Statistical analysis
We calculated descriptive summary statistics, including means and standard deviations for 
continuous variables, and frequencies and standard deviations for categorical variables. 
Demographic characteristics of patients having mastectomy only were compared to those of 
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patients having mastectomy with reconstruction, using t-tests for continuous variables and 
Fisher’s exact tests for categorical variables.
Knowledge—We created knowledge scores for each patient who completed at least 50% 
of the knowledge questions, by dividing the number of correct responses by 9, with missing 
responses counted as incorrect. For individual items, responses were compared between 
treatment groups (reconstruction or not) using Fisher’s exact tests. Factors associated with 
knowledge (socio-demographic and clinical characteristics, provider, and involvement in 
decision making) were examined using linear regression models. We compared overall 
knowledge among participants who completed the survey after seeing a plastic surgeon to 
overall knowledge among others (those who completed the survey before seeing a plastic 
surgeon or who did not see a plastic surgeon) using t-tests.
Involvement in decision making—An involvement score was computed by assigning 1 
possible point for each of the four primary involvement questions (a “yes” response to 
whether or not reconstruction was described as an option, a response of “a lot/some” to 
discussion of advantages, a response of “a lot/some” to discussion of disadvantages, a “yes” 
response to whether the provider asked for the patient’s treatment preference). Descriptive 
statistics were computed for the additional involvement questions and compared using 
Fisher’s exact tests.
RESULTS
Patient characteristics
During the study period July 2012 to February 2014, 214 patients were eligible. Of those 
214 eligible patients, we approached 182 and missed 32 (5 at the surgeon’s request, 27 who 
left clinic before we could approach). Of the 182 we approached, 145 enrolled (80% 
enrollment rate), and 131 completed the survey (72% participation rate) (Figure 1). Five 
participants became ineligible for various reasons (e.g., had surgery elsewhere, completed 
the survey after surgery), leaving a final study population of 126 patients (Table 1). The 
mean age was 53.2 years (SD 12.1), and 24.6% of participants were non-white. About half 
of the participants were college graduates, most were partnered, nearly half were not 
working, and half were privately insured. Most had stage 0-II disease, and one third received 
adjuvant radiation therapy. The immediate reconstruction rate was 40%, consistent with 
national norms.1, 3, 7 The 37 eligible patients who declined enrollment were similar to 
participants in mean age (53.1 years) and insured status (91.9%), but more of them were 
non-white (45.9%, p=0.01), and fewer of them had reconstruction (22%, p=0.05). Survey 
completion date was available for 116 participants. The median time between the first 
surgical oncology visit and survey completion was 15 days (81 days for patients who 
completed the survey after neoadjuvant chemotherapy). Forty of the 116 participants saw a 
plastic surgeon, and 31 out of 40 (78%) completed the survey after seeing the plastic 
surgeon.
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Knowledge
All but five patients (4%) completed at least half of the knowledge questions and had a 
knowledge score computed. The mean knowledge score was 58.5% (SD 16.2) (Table 2), and 
70.2% of participants had a knowledge score of at least 50%. Knowledge was especially low 
for the question on risk of complications, with only 14.3% of participants answering 
correctly that the risk of a major complication in the first two years was 16–40%. Nearly all 
those who answered incorrectly underestimated the risk. Knowledge was also low for the 
two questions on satisfaction, with only 40.0% of participants answering correctly that 
women who have reconstruction and women who have mastectomy only are equally 
satisfied. Knowledge was higher about recovery, number of procedures, recovery after flaps 
versus implants, and future cancer risk. Overall knowledge and knowledge of specific 
questions did not differ by whether or not participants had reconstruction. Overall 
knowledge among participants who completed the survey after a seeing a plastic surgeon 
(mean 62.0) was higher than overall knowledge among participants who completed the 
survey before seeing a plastic surgeon (mean 56.8, p = 0.12), but the difference was not 
statistically significant.
On bivariable analysis, non-white race, less education, lower income, and single relationship 
status were associated with lower knowledge about breast reconstruction (Table 3). On 
multivariable analysis, only non-white race was independently associated with lower 
knowledge (Table 3).
Involvement in decision making
Most patients (92.1%) reported some discussion with a provider about breast reconstruction 
(Table 4), and most (90.4%) reported that they were asked for their preference about 
reconstruction. Although many patients reported discussing the advantages of reconstruction 
some or a lot (57.9%), far fewer reported discussing the disadvantages some or a lot 
(27.8%). This difference was even larger for patients who had reconstruction (76.5% 
advantages versus 31.4% disadvantages).
More of the patients who discussed the disadvantages of reconstruction “a lot” were able to 
correctly answer the question about complication risk (28.6%), compared to the rest of the 
study population (13.4%), but this difference was not statistically significant (p=0.26). Non-
white patients were less likely to report any discussion of disadvantages (20.7%), compared 
to white patients (63.2, p<0.0001).
DISCUSSION
In this population of patients undergoing mastectomy for treatment or prevention of breast 
cancer, decisions about breast reconstruction were only moderately well-informed. Patients 
answered nearly half of the knowledge questions incorrectly, and knowledge about the risk 
of complications was particularly low. Minority women, less educated women, and lower-
income women had lower knowledge.
Our findings of limited knowledge about breast reconstruction are consistent with prior 
research on patient knowledge about reconstruction and other breast cancer treatments. In 
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our prior retrospective study, which also used the Decision Quality Instrument, overall 
knowledge about reconstruction 2.5 years after mastectomy was 37.9%.13 Knowledge about 
breast cancer surgery (mastectomy versus breast conserving surgery) has also been limited 
in prior studies, with patients correctly answering about half of questions about the pros and 
cons of surgery.14–16 Patients also have incomplete knowledge about systemic therapy, with 
frequent overestimation of the survival benefit of chemotherapy.17, 18 Our participants were 
more educated than the average population of women undergoing mastectomy for breast 
cancer, and could all read or speak English. Given the demographics of our study 
population, we expect that knowledge about reconstruction in the breast cancer population at 
large may be even lower than what we found here.
Knowledge about the risk of complications was particularly low at 15%. In our prior 
retrospective study, knowledge about complication risk was even lower, at 3%.13 The DQI 
question on complication risk was developed using the best available evidence about long-
term complications of reconstruction.13, 19 That evidence has found complication rates in the 
range of 20–33%.20–22 Although other studies have reported complication rates in the 5–
15% range, they have been limited to short-term (usually 30-day) complications21, 23, 24 or 
have not reported follow-up duration.25 Low knowledge about reconstruction complications 
is consistent with prior literature on communication about risk. Patients tend to know less 
about the disadvantages than the advantages of treatments,26 and providers’ estimations or 
communications of risk can be biased by optimism.27, 28 Some providers have limited 
numeracy, which affects how well they communicate to patients about risk.29, 30
Our assessment of knowledge had some limitations. Patients answered knowledge questions 
about two weeks after the surgical oncology visit, so they may have forgotten some 
information that the surgeon had discussed. The measured levels of knowledge, however, do 
reflect what patients knew around the time that they were undergoing surgery, which we 
believe is when their knowledge about the procedure is most important. Some patients who 
saw a plastic surgeon completed the survey before the plastic surgery visit, so they may 
eventually have had higher knowledge about reconstruction than what the survey measured. 
We did in fact find that patients who completed the survey after the plastic surgery visit had 
somewhat higher knowledge than those who completed it before the visit or who never saw a 
plastic surgeon, but the difference was not statistically significant. Just how much knowledge 
about reconstruction patients ought to have, if they are not considering reconstruction, is not 
entirely clear. Surgical oncologists may choose not to discuss the disadvantages of 
reconstruction with patients who are not interested in the procedure, and this is reasonable. 
Interestingly, patients in this sample who were having reconstruction were no more 
knowledgeable about complications than patients not having reconstruction.
Patients in this sample were more involved in the decision making process than has been 
reported before. Most patients (92.1%) reported that their provider discussed the option of 
reconstruction and that their provider asked for their preference about reconstruction 
(90.4%). In retrospective, multi-site, and population-based studies of breast cancer survivors, 
a smaller percentage (74–81%) of patients recalled a discussion about reconstruction with 
their provider.6, 8, 13, 31 One possible explanation for our finding of higher involvement is 
that we asked patients about their decision approximately 2 weeks after the surgical 
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oncology visit and prior to surgery, whereas most other studies have asked about 
involvement months or years later. Thus, patients in our study may have had better recall of 
their involvement in the consultation than in other studies. Our study was limited by its 
setting of a single academic institution, and by a population that was more educated and 
wealthier than the average. Thus findings about involvement may not be generalizable to the 
breast cancer patient population at large. We expect that involvement in this study may have 
been higher than the average.
Lower knowledge was associated with non-white race, less education, lower income, and 
single relationship status, on bivariable analysis. In addition, non-white race was 
independently associated with lower knowledge. We are uncertain why this was the case. We 
attempted to examine potential confounders of the relationship between race and knowledge, 
such as education, insurance, income, and involvement. Our sample size was somewhat 
limited, however, and we did not measure some potentially important variables, such as 
literacy or numeracy. Our sample was also limited to women who could read or speak 
English, so we cannot comment on the knowledge or decisional involvement of breast 
cancer patients who do not communicate in English. Such women would be important to 
future studies, since low-acculturated Latina women and minority women in general are less 
likely to have breast reconstruction.7 Finally, we did not directly observe patient involvement 
in the decision. In the future, audio recordings of the patient-provider conversation could 
provide some insight.
How much knowledge a patient must have in order to make an informed choice is not 
entirely clear. We based our approach to evaluating decisions on a theoretical framework of 
decision quality which requires that patients understand the advantages and disadvantages of 
the options and make a choice consistent with their values.32–35 Our measure of knowledge 
was based on that framework36 and included questions about facts that patients and 
providers had deemed critical to the decision about reconstruction.19 One conservative 
definition of being informed would require correct responses to 50% of knowledge 
questions.37 By this definition, 70% of our sample was minimally informed. Different 
opinions exist about what constitutes a minimal acceptable level of knowledge, however, and 
further research on this issue would be useful.
Conclusion
Women undergoing mastectomy in this sample were highly involved in the decision about 
breast reconstruction, but they had major deficits in knowledge about the procedure. 
Knowledge about the risk of complications was particularly low. Providers appeared to have 
discussed the advantages of reconstruction more than its disadvantages.
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Figure 1. 
Study flow diagram
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Table 1
Demographic and treatment characteristics of study sample.
% of patients
Total Mastectomy Only Mastectomy w/Reconstruction
N=126 N=75 N=51 p
Age – mean (SD) 53.2 (12.1) 54.8 (13.8) 50.9 (8.5) 0.08
Education 0.10
 High school or less 16.7 22.7 7.8
 Some college 34.9 32.0 39.2
 College graduate or more 47.6 44.0 52.9
Marital status 0.01
 Married/committed 65.1 54.7 80.4
 Single/divorced/separated/widowed 34.1 44.0 19.6
Race 0.55
 White 75.4 72.0 80.4
 Black 18.3 21.3 13.7
 Other/multiracial 6.3 6.7 5.9
Ethnicity 0.23
 Hispanic 4.8 4.0 5.9
 Not Hispanic 92.1 90.7 94.1
Employment status 0.26
 Working full time 39.7 33.3 49.0
 Working part time/temporary leave 15.1 17.3 11.8
 Not working 43.7 46.7 39.2
Annual household income 0.01
 < $30,000 29.4 38.7 15.7
 $30,000 – $59,999 17.5 20.0 13.7
 $60,000 – $100,000 19.0 18.7 19.6
 over $100,000 30.2 20.0 45.1
Primary insurance 0.01
 No insurance 6.3 6.7 5.9
 Medicaid only 7.1 12.0 0.0
 Medicare or Tricare 31.0 34.7 25.5
 Private insurance 55.6 46.7 68.6
Diagnosis and stage <0.0001
 No malignancy 13.5 1.3 31.4
 Ductal carcinoma in situ 16.7 9.3 27.5
 Invasive ductal carcinoma
  Stage I 35.7 37.3 33.3
  Stage II 20.6 29.3 7.8
  Stage III 13.5 22.7 0.0
Surgical treatment <0.0001
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% of patients
Total Mastectomy Only Mastectomy w/Reconstruction
N=126 N=75 N=51 p
 Unilateral mastectomy 55.6 72.0 31.4
 Bilateral mastectomy 44.4 28.0 68.6
Adjuvant radiation <0.0001
 Yes 31.7 49.3 5.9
 No 68.3 50.7 94.1
Adjuvant chemotherapy 0.01
 Yes 25.4 33.3 13.7
 No 74.6 66.7 86.3
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Table 2
Knowledge of specific topics about breast reconstruction after mastectomy, by treatment
% of patients
Question and responses* (correct response in bold italics)
Total Mastectomy Only Mastectomy w/Reconstruction
n=126 n=75 n=51 p**
Which women are more satisfied after mastectomy? 0.46
 Women who have reconstruction 55.6 50.7 62.7
 Women who do not have reconstruction 1.6 2.7 0.0
 They are equally satisfied 38.1 41.3 33.3
Which has a longer recovery time? 0.21
 Mastectomy without reconstruction 8.7 10.7 5.9
 Mastectomy with reconstruction 76.2 72.0 82.4
 They have the same recovery time 11.9 12.0 11.8
Which is more likely to require more than one surgery or 
procedure?
0.03
 Mastectomy without reconstruction 15.1 21.3 5.9
 Mastectomy with reconstruction 77.8 70.7 88.2
 They require the same number 3.2 4.0 2.0
After which reconstruction are women more satisfied with the 
look and feel?
0.57
 Implants 26.2 28.0 23.5
 Flap procedures 34.1 32.0 37.3
 Both are about the same 33.3 30.7 37.3
Which surgery is easier on the body, heals faster? 0.34
 Implants are easier 65.1 61.3 70.6
 Flaps are easier 8.7 9.3 7.8
 Implants and flaps are equally easy 19.8 20.0 19.6
Out of 100 women who have reconstruction, how many will 
have a major complication, within 2 years?
0.12
 Fewer than 5 36.5 34.7 39.2
 5–15 43.7 38.7 51.0
 16–40 14.3 18.7 7.8
 More than 40 0.8 1.3 0.0
How does radiation affect the number of complications? 0.18
 Radiation increases the # of complications 67.5 62.7 74.5
 Radiation decreases the # of complications 7.9 9.3 5.9
 Radiation does not affect the # of complications 20.6 21.3 19.6
How does reconstruction affect future screening? 0.46
 Makes it harder to find cancer 24.6 25.3 23.5
 Makes it easier to find cancer 5.6 6.7 3.9
 Has little or no effect on finding cancer 61.9 58.7 66.7
How does reconstruction affect chance of cancer coming back? 0.67
 Increases the chance of cancer coming back 3.2 5.3 0.0
Ann Surg. Author manuscript; available in PMC 2017 March 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Lee et al. Page 15
% of patients
Question and responses* (correct response in bold italics)
Total Mastectomy Only Mastectomy w/Reconstruction
n=126 n=75 n=51 p**
 Decreases the chance of cancer coming back 15.1 8.0 25.5
 Has little or no effect on cancer coming back 75.4 77.3 72.5
Overall knowledge (out of 100) – mean (SD) 58.5 (16.2) 57.9 (16.6) 59.3 (15.8) 0.66
*Some wording has been shortened to fit this table
**Comparison between % correct vs incorrect/missing
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Table 3
Bivariable and multivariable (linear regression) analyses of factors associated with knowledge (significant 
factors in bold)
Bivariable Multivariable
Characteristic Mean knowledge score (% correct) p Regression coefficient p
Age 0.83 −0.13 0.97
 < 50 years 58.1
 >=50 years* 58.8
Race <0.0001 11.97 0.00
 White 62.0
 Non−white* 46.8
Education 0.06 −2.22 0.60
 High school or less 52.1
 College or more* 59.6
Annual income 0.01 −4.67 0.22
 < $60,000 54.2
 >= $60,000* 62.0
Marital Status 0.14 −2.01 0.59
 Partnered 60.0
 Single/divorced/widowed* 55.3
Diagnosis
 No malignancy 59.5 0.89 −2.51 0.62
 DCIS 56.1 0.48 −3.11 0.44
 Invasive breast cancer* 58.9
Surgical cancer treatment 0.18 −2.99 0.37
 Unilateral mastectomy 56.7
 Bilateral mastectomy* 60.7
Insurance 0.44 −2.33 0.70
 No 54.2
 Yes* 58.8
Involvement score (0–4) 0.99 −0.38 0.90
 <3 points 58.8
 >=3 points 58.8
*
referent group
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Table 4
Involvement in decision making
% of patients
Total Mastectomy Only Mastectomy w/Reconstruction
Question and responses N=126 N=75 N=51 p
Have any of your providers discussed breast reconstruction as 
an option for you?
0.01
 Yes 92.1 86.7 100.0
 No 7.9 13.3 0.0
Have any of your providers discussed using a prosthesis as an 
option for you?
0.27
 Yes 46.4 41.9 52.9
 No 53.6 58.1 47.1
How much have you and your providers discussed reasons to 
have breast reconstruction?
<0.001
 A lot/Some 57.9 45.3 76.5
 A little/Not at all 42.1 54.7 23.5
How much have you and your providers discussed reasons not 
to have breast reconstruction?
0.54
 A lot/Some 27.8 25.3 31.4
 A little/Not at all 72.2 74.7 68.6
Have any of your providers asked whether or not you want to 
have reconstruction?
0.03
 Yes 90.4 85.3 98.0
 No 9.6 14.7 2.0
How much have you and your providers talked about your 
concerns about appearance?
<0.0001
 A lot/Some 44.4 28.8 66.7
 A little/Not at all 55.6 71.2 33.3
How much are you involved in making the decision about breast 
reconstruction?
0.36
 More than I want 9.1 9.9 8.0
 About as much as I want 88.4 85.9 92.0
 Less than I want 2.5 4.2 0.0
*Some questions have been reworded to fit this table.
**Not all responses add to 100% due to missing data.
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